Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-188-8 | CAS number: 127184-53-6
Substance identity
Identification
- Display Name:
- 2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3,5-bis({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide; 2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3-({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-5-({1,3,3-trimethyl-5-[2,4,6-trioxo-3,5-bis(3,3,5-trimethyl-5-{[(2-oxoazepane-1-carbonyl)amino]methyl}cyclohexyl)-1,3,5-triazinan-1-yl]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide
- EC Number:
- 603-188-8
- CAS Number:
- 127184-53-6
- Molecular formula:
- Exact identification is not feasible
- IUPAC Name:
- 2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3,5-bis({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide; 2-oxo-N-(3,3,5-trimethyl-5-{[2,4,6-trioxo-3-({1,3,3-trimethyl-5-[(2-oxoazepane-1-carbonyl)amino]cyclohexyl}methyl)-5-({1,3,3-trimethyl-5-[2,4,6-trioxo-3,5-bis(3,3,5-trimethyl-5-{[(2-oxoazepane-1-carbonyl)amino]methyl}cyclohexyl)-1,3,5-triazinan-1-yl]cyclohexyl}methyl)-1,3,5-triazinan-1-yl]methyl}cyclohexyl)azepane-1-carboxamide
Type of Substance
- Composition:
- UVCB
- Origin:
- organic
Substance Identifiers open all close all
Compositions
Boundary Composition(s) open all close all
- State Form:
- solid: bulk
Constituent 1
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=3, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C54 H87 N9 O9
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=3, blocked with hexahydro-2H-azepin-2-one
Constituent 2
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=5, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C84 H134 N14 O14
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=5, blocked with hexahydro-2H-azepin-2-one
Constituent 3
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=7 or higher, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- >= C114 H181 N19 O19
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=7 or higher, blocked with hexahydro-2H-azepin-2-one
Constituent 4
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
Constituent 5
- Reference substance name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- EC Number:
- 259-920-8
- EC Name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- CAS Number:
- 55954-19-3
- Molecular formula:
- C24 H40 N4 O4
- IUPAC Name:
- N-[3-[[[(Hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl-3,5,5-trimethylcyclohexyl]hexahydro-2-oxo-1H-azepine-1-carboxamide
Legal Entity Composition(s) open all close all
- State Form:
- solid: bulk
Constituent 1
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=3, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C54 H87 N9 O9
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=3, blocked with hexahydro-2H-azepin-2-one
Constituent 2
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=5, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C84 H134 N14 O14
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=5, blocked with hexahydro-2H-azepin-2-one
Constituent 3
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=7 or higher, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- >= C114 H181 N19 O19
- IUPAC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomerization product (isocyanurate type), n=7 or higher, blocked with hexahydro-2H-azepin-2-one
Constituent 4
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
Constituent 5
- Reference substance name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- EC Number:
- 259-920-8
- EC Name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- CAS Number:
- 55954-19-3
- Molecular formula:
- C24 H40 N4 O4
- IUPAC Name:
- N-[3-[[[(Hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl-3,5,5-trimethylcyclohexyl]hexahydro-2-oxo-1H-azepine-1-carboxamide
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- N,N',N''-[(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris[methylene(3,5,5-trimethylcyclohexane-3,1-diyl)]]tris[hexahydro-2-oxo-1H-azepine-1-carboxamide]
- EC Number:
- 273-482-5
- EC Name:
- N,N',N''-[(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris[methylene(3,5,5-trimethylcyclohexane-3,1-diyl)]]tris[hexahydro-2-oxo-1H-azepine-1-carboxamide]
- CAS Number:
- 68975-83-7
- Molecular formula:
- C54H87N9O9
- IUPAC Name:
- N,N',N''-[(2,4,6-trioxo-1,3,5-triazinane-1,3,5-triyl)tris[methylene(3,5,5-trimethylcyclohexane-3,1-diyl)]]tris(2-oxoazepane-1-carboxamide)
Constituent 2
- Reference substance name:
- 2-oxo-N-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[3,3,5-trimethyl-5-({2,4,6-trioxo-3,5-bis[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]azepane-1-carboxamide
- Molecular formula:
- C84H134N14O14
- IUPAC Name:
- 2-oxo-N-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[3,3,5-trimethyl-5-({2,4,6-trioxo-3,5-bis[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]azepane-1-carboxamide
Constituent 3
- Reference substance name:
- 2-oxo-N-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[(1,3,3-trimethyl-5-{2,4,6-trioxo-3,5-bis[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}cyclohexyl)methyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]azepane-1-carboxamide
- Molecular formula:
- >= C114H181N19O19 (IPDI-Isocyanurate n=3, caprolactam-blocked)
- IUPAC Name:
- 2-oxo-N-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[3,3,5-trimethyl-5-({2,4,6-trioxo-3-[(1,3,3-trimethyl-5-{2,4,6-trioxo-3,5-bis[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}cyclohexyl)methyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]-5-[(1,3,3-trimethyl-5-{[(2-oxoazepan-1-yl)carbonyl]amino}cyclohexyl)methyl]-1,3,5-triazinan-1-yl}methyl)cyclohexyl]azepane-1-carboxamide
Constituent 4
- Reference substance name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- EC Number:
- 259-920-8
- EC Name:
- Hexahydro-N-[3-[[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl]-3,5,5-trimethylcyclohexyl]-2-oxo-1H-azepine-1-carboxamide
- CAS Number:
- 55954-19-3
- Molecular formula:
- C24 H40 N4 O4
- IUPAC Name:
- N-[3-[[[(Hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]methyl-3,5,5-trimethylcyclohexyl]hexahydro-2-oxo-1H-azepine-1-carboxamide
Constituent 5
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
Constituent 6
- Reference substance name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate
- EC Number:
- 223-861-6
- EC Name:
- 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate
- CAS Number:
- 4098-71-9
- Molecular formula:
- C12H18N2O2
- IUPAC Name:
- 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
Composition(s) generated upon use
Other types of composition(s)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
